Clinical Trial Update: Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) [Phase 2]

View source ↗

Summary

This update describes the Phase 2 PRECISION 1 basket trial of nab-sirolimus for malignant solid tumors with pathogenic TSC1/TSC2 alterations, which is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor
• Tuberous Sclerosis Complex

Drugs mentioned

• nab-sirolimus (sirolimus (nanoparticle albumin-bound formulation))

Snippet

Sponsor: Aadi Bioscience, Inc. | Conditions: Tumor, Tumor, Solid | Phase 2 | Status: ACTIVE_NOT_RECRUITING